Rakesh Dixit

Rakesh Dixit

Company: Bionavigen

Job title: Chief Executive Officer


Developing Smart & Fitfor- Purpose ADC Development Strategies to Improve Safety & Efficacy 10:00 am

Understanding the importance of the target and the engineered antibody Evaluating what payloads are better suited for low vs. high target expression? Discussing whether on target toxicities can be minimized by intelligent engineering and combination approaches Sharing translational approaches to maximize the value of clinical trialsRead more

day: Track B - Pre-conf-AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.